SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging following a strong quarterly earnings report, driven by accelerating AI data center demand and optimistic forward-looking guidance. Investors are actively discussing the stock's parabolic trajectory and aggressive price target upgrades, with many comparing its current momentum to other chip sector leaders while debating whether the rapid valuation expansion is sustainable.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk (SNDK) is experiencing intense parabolic growth and high volatility, fueled by structural memory supply shortages and aggressive demand for AI-focused data center hardware. The community is actively debating whether this movement represents a sustainable long-term re-rating driven by fundamental scarcity or an unsustainable speculative bubble reminiscent of past market excesses.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as community members spar over whether the stock is ripe for a short squeeze ahead of upcoming federal cannabis rescheduling catalysts or if it is a long-term underperformer plagued by dilution and poor leadership. Despite the divisive sentiment, discourse is heavily focused on whether current levels represent a massive buying opportunity or a signal to avoid the ticker entirely.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors rally behind the stock's global expansion strategy and the potential for a short squeeze amid heavy short interest. The community is actively discussing clinical data updates for Anktiva, upcoming earnings reports, and the intensifying scrutiny surrounding the FDA's regulatory environment.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as a major beneficiary of the AI memory supercycle, with community discussion highlighting an insatiable, multi-year supply-demand imbalance for HBM and enterprise SSDs. Investors are actively debating the sustainability of the stock's parabolic momentum, while many bullish participants argue that the company's strong forward earnings potential and critical role in AI infrastructure justify further upside.

Ethereum Classic

Ethereum Classic is experiencing significant community chatter as investors debate its long-term potential compared to other altcoins during a period of prolonged market volatility. Enthusiasts remain focused on its Proof of Work origins and upcoming technical upgrades, while others express frustration over stagnant price action and its distance from previous highs.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging after delivering strong earnings and updated guidance that reassured investors about the company's margin recovery and sustained demand for AI infrastructure. The community is actively debating the stock's potential for a massive short squeeze and long-term re-rating, highlighting that the company's current valuation remains significantly undervalued compared to its peers.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is surging following a multi-year colocation deal with AI compute firm Cerebras Systems, fueling intense community debate over its long-term potential versus concerns regarding dilution and volatility. Traders are actively monitoring the stock for momentum-driven gains, with significant discussion focused on whether the infrastructure contract will trigger a major re-rating as the Cerebras IPO approaches.

Wormhole is a cross-chain messaging protocol that enables secure transfers of data or tokens across different blockchain networks. It supports a variety of applications, including DeFi, NFTs, and governance, by allowing data to be moved between blockchains efficiently and securely. Wormhole employs multiple verification methods to ensure the integrity and validity of the data transmitted through its network.

Wormhole

Wormhole is seeing increased engagement as the community reacts to its role in cross-chain interoperability, particularly its integration with institutional partners and major networks like Ripple. Investors are actively debating the tokens potential for a breakout, driven by discussions around strategic reserves, tokenomics updates, and its utility as a bridge across blockchain ecosystems.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is surging following positive Phase 2 trial results for its drug candidate abdakibart, which successfully met primary endpoints for treating hidradenitis suppurativa. While the community is actively debating the potential for a short squeeze and the impact of a concurrently announced public offering, sentiment remains split between excitement over clinical progress and concerns regarding dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Exelixis (EXEL) Tops Q1 Earnings Estimates

Exelixis (EXEL) delivered earnings and revenue surprises of +15.55% and -0.29%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Immunome, Inc. (the Company) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on May 1, 2026, the...

Truist Financial Upgrades Immunome (NASDAQ:IMNM) to Strong-Buy

Truist Financial upgraded shares of Immunome to a "strong-buy" rating in a report on Monday...

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Lags Revenue Estimates

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of -12.39% and -82.62%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Immunome (IMNM) to Release Earnings on Monday

Immunome (NASDAQ:IMNM) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-immunome-inc-stock...

Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults with Desmoid Tumors

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced the submission of a New Drug Application...

Immunome Announces Oral Presentation of Phase 3 RINGSIDE Data at 2026 ASCO Annual Meeting

Immunome, Inc. (Immunome) (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today announced that data from RINGSIDE, its...

JPMorgan Chase & Co. Cuts Stock Holdings in Immunome, Inc. $IMNM

JPMorgan Chase & Co. decreased its stake in shares of Immunome, Inc. (NASDAQ:IMNM - Free Report) by 94.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 32,603 shares of the company's stock after selling 5...

Immunome, Inc. (NASDAQ:IMNM) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Immunome, Inc. (NASDAQ:IMNM - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eleven research firms that are covering the firm, Marketbeat Ratings...

Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More

Key Points9,438 shares were sold for a transaction value of ~$204,000 on April 2, 2026...

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Immunome Inc

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

Current Price	$23.11
Prev Close	$23.33
Open	$23.49
Dividend Yield	0.00%
50-Day Moving Average	$21.96
Beta	1.51
Avg. Volume	976,741.54
PE Ratio	-9.52

52-Week High	$27.65
52-Week Low	$7.15
Market Capitalization	$2.64B
EPS (Annual)	-$2.43
Price to Book	4.12
Revenue Per Employee	$39,214.69

IMNM
Immunome Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMNM News

IMNMImmunome Inc